Filed In:
Cytoxan - Cyclophosphamide - Dosage - Side Effects - Drug Interactions
Cytoxan (Neosar, cyclophosphamide) drug information, dosage, side effects, drug interactions, and warnings. Cyclophosphamide, brand name drugs include Cytoxan and Neosar, is an immunosuppresant medication used in the treatment of rheumatoid arthritis, vasculitis and severe lupus that affects internal organs.
- A - Z: Arthritis Drugs
- A - Z: Lower Drug Costs
- B-Cell Depletion Therapy
- DMARDs
- Lupus
- Rheumatoid Arthritis
- Vasculitis
What Are Cytotoxic Drugs?
Cytotoxic drugs, such as methotrexate, Cytoxan, and Imuran are used to treat rheumatoid arthritis and some other rheumatic diseases. There are potentially serious side effects associated with these drugs, but methotrexate appears to have the best safety profile. Learn more about cytotoxic drugs.
Drugs A-Z - Cytoxan / Cyclophosphamide Tablets
Patient education for Cytoxan / cyclophosphamide tablets. Cytoxan is used to treat cancer. Cytoxan also treats a number of immune-related diseases or conditions, such as systemic lupus erythematosus (SLE), lupus nephritis, rheumatoid arthritis or organ transplant rejection.
The Facts Of DMARDs
Learn about disease-modifying anti-rheumatic drugs such as methotrexate and gold.
B-Cell: Is Progress Being Made?
The treatment, which involves removal of B-lymphocytes by using a combination of rituximab, prednisoline (a steroid), and cyclophosphamide (also known as cytoxan) was touted as a potential "cure" for rheumatoid arthritis. Professor Jonathan CW Edwards lets us know where things stand.
Drug Profile: Cyclophosphamide (Cytoxan)
Drug profile and essential information for Cyclophosphamide (Cytoxan), from UMM.
ACR Patient Education: Cyclophosphamide (Cytoxan)
Cyclophosphamide (Cytoxan) belongs to a class of drugs known as alkylating agents, which were originally developed and are still used to treat some types of cancer. It is in the class of medications referred to as immunosuppressants – medicines that can decrease the immune response, from ACR.
